2023年伊斯法罕人工智能赛事:黄斑病理检测大赛。

IF 1.1 Q4 ENGINEERING, BIOMEDICAL
Journal of Medical Signals & Sensors Pub Date : 2024-01-23 eCollection Date: 2025-01-01 DOI:10.4103/jmss.jmss_47_24
Farnaz Sedighin, Maryam Monemian, Zahra Zojaji, Ahmadreza Montazerolghaem, Mohammad Amin Asadinia, Seyed Mojtaba Mirghaderi, Seyed Amin Naji Esfahani, Mohammad Kazemi, Reza Mokhtari, Maryam Mohammadi, Mohadese Ramezani, Mahnoosh Tajmirriahi, Hossein Rabbani
{"title":"2023年伊斯法罕人工智能赛事:黄斑病理检测大赛。","authors":"Farnaz Sedighin, Maryam Monemian, Zahra Zojaji, Ahmadreza Montazerolghaem, Mohammad Amin Asadinia, Seyed Mojtaba Mirghaderi, Seyed Amin Naji Esfahani, Mohammad Kazemi, Reza Mokhtari, Maryam Mohammadi, Mohadese Ramezani, Mahnoosh Tajmirriahi, Hossein Rabbani","doi":"10.4103/jmss.jmss_47_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Computer-aided diagnosis (CAD) methods have become of great interest for diagnosing macular diseases over the past few decades. Artificial intelligence (AI)-based CADs offer several benefits, including speed, objectivity, and thoroughness. They are utilized as an assistance system in various ways, such as highlighting relevant disease indicators to doctors, providing diagnosis suggestions, and presenting similar past cases for comparison.</p><p><strong>Methods: </strong>Much specifically, retinal AI-CADs have been developed to assist ophthalmologists in analyzing optical coherence tomography (OCT) images and making retinal diagnostics simpler and more accurate than before. Retinal AI-CAD technology could provide a new insight for the health care of humans who do not have access to a specialist doctor. AI-based classification methods are critical tools in developing improved retinal AI-CAD technology. The Isfahan AI-2023 challenge has organized a competition to provide objective formal evaluations of alternative tools in this area. In this study, we describe the challenge and those methods that had the most successful algorithms.</p><p><strong>Results: </strong>A dataset of OCT images, acquired from normal subjects, patients with diabetic macular edema, and patients with other macular disorders, was provided in a documented format. The dataset, including the labeled training set and unlabeled test set, was made accessible to the participants. The aim of this challenge was to maximize the performance measures for the test labels. Researchers tested their algorithms and competed for the best classification results.</p><p><strong>Conclusions: </strong>The competition is organized to evaluate the current AI-based classification methods in macular pathology detection. We received several submissions to our posted datasets that indicate the growing interest in AI-CAD technology. The results demonstrated that deep learning-based methods can learn essential features of pathologic images, but much care has to be taken in choosing and adapting appropriate models for imbalanced small datasets.</p>","PeriodicalId":37680,"journal":{"name":"Journal of Medical Signals & Sensors","volume":"15 ","pages":"3"},"PeriodicalIF":1.1000,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11870325/pdf/","citationCount":"0","resultStr":"{\"title\":\"Isfahan Artificial Intelligence Event 2023: Macular Pathology Detection Competition.\",\"authors\":\"Farnaz Sedighin, Maryam Monemian, Zahra Zojaji, Ahmadreza Montazerolghaem, Mohammad Amin Asadinia, Seyed Mojtaba Mirghaderi, Seyed Amin Naji Esfahani, Mohammad Kazemi, Reza Mokhtari, Maryam Mohammadi, Mohadese Ramezani, Mahnoosh Tajmirriahi, Hossein Rabbani\",\"doi\":\"10.4103/jmss.jmss_47_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Computer-aided diagnosis (CAD) methods have become of great interest for diagnosing macular diseases over the past few decades. Artificial intelligence (AI)-based CADs offer several benefits, including speed, objectivity, and thoroughness. They are utilized as an assistance system in various ways, such as highlighting relevant disease indicators to doctors, providing diagnosis suggestions, and presenting similar past cases for comparison.</p><p><strong>Methods: </strong>Much specifically, retinal AI-CADs have been developed to assist ophthalmologists in analyzing optical coherence tomography (OCT) images and making retinal diagnostics simpler and more accurate than before. Retinal AI-CAD technology could provide a new insight for the health care of humans who do not have access to a specialist doctor. AI-based classification methods are critical tools in developing improved retinal AI-CAD technology. The Isfahan AI-2023 challenge has organized a competition to provide objective formal evaluations of alternative tools in this area. In this study, we describe the challenge and those methods that had the most successful algorithms.</p><p><strong>Results: </strong>A dataset of OCT images, acquired from normal subjects, patients with diabetic macular edema, and patients with other macular disorders, was provided in a documented format. The dataset, including the labeled training set and unlabeled test set, was made accessible to the participants. The aim of this challenge was to maximize the performance measures for the test labels. Researchers tested their algorithms and competed for the best classification results.</p><p><strong>Conclusions: </strong>The competition is organized to evaluate the current AI-based classification methods in macular pathology detection. We received several submissions to our posted datasets that indicate the growing interest in AI-CAD technology. The results demonstrated that deep learning-based methods can learn essential features of pathologic images, but much care has to be taken in choosing and adapting appropriate models for imbalanced small datasets.</p>\",\"PeriodicalId\":37680,\"journal\":{\"name\":\"Journal of Medical Signals & Sensors\",\"volume\":\"15 \",\"pages\":\"3\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2024-01-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11870325/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medical Signals & Sensors\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jmss.jmss_47_24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Signals & Sensors","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jmss.jmss_47_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:在过去的几十年里,计算机辅助诊断(CAD)方法已经成为黄斑疾病诊断的重要手段。基于人工智能(AI)的cad提供了几个好处,包括速度、客观性和彻彻性。通过向医生突出相关疾病指标、提供诊断建议、介绍过去类似病例进行比较等方式,将其作为辅助系统加以利用。方法:更具体地说,视网膜ai - cad已经开发出来,以协助眼科医生分析光学相干断层扫描(OCT)图像,使视网膜诊断比以前更简单、更准确。视网膜AI-CAD技术可以为无法获得专业医生的人类提供新的医疗保健见解。基于人工智能的分类方法是开发改进的视网膜AI-CAD技术的关键工具。Isfahan AI-2023挑战赛组织了一场竞赛,为该领域的替代工具提供客观的正式评估。在本研究中,我们描述了挑战和那些拥有最成功算法的方法。结果:从正常受试者、糖尿病性黄斑水肿患者和其他黄斑疾病患者中获得的OCT图像数据集以文档格式提供。数据集,包括标记的训练集和未标记的测试集,可供参与者访问。这个挑战的目的是最大限度地提高测试标签的性能指标。研究人员测试了他们的算法,并竞争最佳分类结果。结论:本次大赛旨在评价目前基于人工智能的黄斑病理检测分类方法。我们收到了几份提交给我们发布的数据集,表明对AI-CAD技术的兴趣日益浓厚。结果表明,基于深度学习的方法可以学习病理图像的基本特征,但在选择和适应不平衡小数据集的适当模型时需要非常小心。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Isfahan Artificial Intelligence Event 2023: Macular Pathology Detection Competition.

Isfahan Artificial Intelligence Event 2023: Macular Pathology Detection Competition.

Isfahan Artificial Intelligence Event 2023: Macular Pathology Detection Competition.

Isfahan Artificial Intelligence Event 2023: Macular Pathology Detection Competition.

Background: Computer-aided diagnosis (CAD) methods have become of great interest for diagnosing macular diseases over the past few decades. Artificial intelligence (AI)-based CADs offer several benefits, including speed, objectivity, and thoroughness. They are utilized as an assistance system in various ways, such as highlighting relevant disease indicators to doctors, providing diagnosis suggestions, and presenting similar past cases for comparison.

Methods: Much specifically, retinal AI-CADs have been developed to assist ophthalmologists in analyzing optical coherence tomography (OCT) images and making retinal diagnostics simpler and more accurate than before. Retinal AI-CAD technology could provide a new insight for the health care of humans who do not have access to a specialist doctor. AI-based classification methods are critical tools in developing improved retinal AI-CAD technology. The Isfahan AI-2023 challenge has organized a competition to provide objective formal evaluations of alternative tools in this area. In this study, we describe the challenge and those methods that had the most successful algorithms.

Results: A dataset of OCT images, acquired from normal subjects, patients with diabetic macular edema, and patients with other macular disorders, was provided in a documented format. The dataset, including the labeled training set and unlabeled test set, was made accessible to the participants. The aim of this challenge was to maximize the performance measures for the test labels. Researchers tested their algorithms and competed for the best classification results.

Conclusions: The competition is organized to evaluate the current AI-based classification methods in macular pathology detection. We received several submissions to our posted datasets that indicate the growing interest in AI-CAD technology. The results demonstrated that deep learning-based methods can learn essential features of pathologic images, but much care has to be taken in choosing and adapting appropriate models for imbalanced small datasets.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Medical Signals & Sensors
Journal of Medical Signals & Sensors ENGINEERING, BIOMEDICAL-
CiteScore
2.30
自引率
0.00%
发文量
53
审稿时长
33 weeks
期刊介绍: JMSS is an interdisciplinary journal that incorporates all aspects of the biomedical engineering including bioelectrics, bioinformatics, medical physics, health technology assessment, etc. Subject areas covered by the journal include: - Bioelectric: Bioinstruments Biosensors Modeling Biomedical signal processing Medical image analysis and processing Medical imaging devices Control of biological systems Neuromuscular systems Cognitive sciences Telemedicine Robotic Medical ultrasonography Bioelectromagnetics Electrophysiology Cell tracking - Bioinformatics and medical informatics: Analysis of biological data Data mining Stochastic modeling Computational genomics Artificial intelligence & fuzzy Applications Medical softwares Bioalgorithms Electronic health - Biophysics and medical physics: Computed tomography Radiation therapy Laser therapy - Education in biomedical engineering - Health technology assessment - Standard in biomedical engineering.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信